journal
Journals Clinical Diabetes and Endocrin...

Clinical Diabetes and Endocrinology

https://read.qxmd.com/read/38641841/comparison-of-therapeutic-effects-of-n-acetylcysteine-with-pregabalin-in-improving-the-clinical-symptoms-of-painful-diabetic-neuropathy-a-randomized-double-blind-clinical-trial
#1
JOURNAL ARTICLE
Firozeh Sajedi, Arman Abdi, Maryam Mehrpooya, Vida Faramarzi, Younes Mohammadi, Fateme Sheida
OBJECTIVES: Painful diabetic neuropathy (PDN) is highly prevalent and annoyingly in patients with diabetes. The aim of this study was to investigate the effects of oral N-acetylcysteine (NAC) compared to pregabalin in PDN. METHODS: One hundred two eligible patients with type 2 diabetes and PDN were randomly recievied pregabalin (150 mg/day) or N-Acetylcysteine (NAC) (600 mg/ twice a day) for 8 weeks. Mean pain score, Sleep interference score (SIS), Patient Global Impression of Change (PGIC), Clinical Global Impression of Change (CGIC), and also, serum levels of total antioxidant capacity (TAC), total thiol groups (TTG), catalase activity (CAT), nitric oxide (NO), and malondialdehyde (MDA) were assessed at baseline and at the end of the study...
April 19, 2024: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/38616273/sodium-bicarbonate-and-intubation-in-severe-diabetic-ketoacidosis-are-we-too-quick-to-dismiss-them
#2
JOURNAL ARTICLE
Manudi Vidanapathirana
Management of diabetic ketoacidosis (DKA) has internationally established guidelines. However, management of severe, refractory DKA with multiple contributors to acidosis, and management of DKA in patients with altered mentation, remain ambiguous. Use of sodium bicarbonate and intubation in DKA are unpopular treatment practices, but warrant consideration in these unique clinical scenarios. This paper describes a 61-year-old Sri Lankan female who presented with severe DKA, seizures and altered level of consciousness...
April 15, 2024: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/38594776/potential-risk-of-gestational-diabetes-mellitus-in-females-undergoing-in-vitro-fertilization-a-pilot-study
#3
JOURNAL ARTICLE
Yehia Moustafa Ghanem, Yasser El Kassar, May Mohamed Magdy, Mohamed Amara, Noha Gaber Amin
BACKGROUND: Most of the cases of hyperglycemia during pregnancy are attributed to gestational diabetes mellitus (GDM) (75-90%). Women diagnosed with GDM are at an increased risk for complications during pregnancy and delivery. This observational prospective study aimed to investigate the potential risk of GDM among Egyptian females following in vitro fertilization (IVF) pregnancies compared to spontaneous pregnancies (SC). METHODS: This prospective cohort study included normoglycemic females without any history of dysglycemia before this conception...
April 10, 2024: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/38523307/dermatological-side-effects-of-dipeptidyl-peptidase-4-inhibitors-in-diabetes-management-a-comprehensive-review
#4
REVIEW
Shirin Zaresharifi, Mahtab Niroomand, Sarina Borran, Sahar Dadkhahfar
Dipeptidyl peptidase-4 (DPP-4) inhibitors are a class of drugs that enhance the incretin-insulin pathway and offer effective glycemic control in type 2 diabetes mellitus. However, these drugs may be associated with various dermatological side effects, ranging from mild to severe. This review article summarizes the current literature on the dermatological side effects of DPP-4 inhibitors, including bullous pemphigoid, severe cutaneous adverse drug reactions, fixed drug eruptions, and other mucocutaneous reactions...
March 25, 2024: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/38486333/social-learning-based-health-literacy-promotion-on-the-self-efficacy-and-social-anxiety-of-adolescents-with-type-1-diabetes
#5
JOURNAL ARTICLE
Jamalodin Begjani, Akram Sadat Sadat Hosseini, Hedieh Saneifard, Vida Rahimi Hasanabad
BACKGROUND AND OBJECTIVE: Type 1 diabetes mellitus one of the biggest health concerns around the world, is difficult to manage during adolescence. Among the non-medical methods of controlling this disease is empowerment through self-efficacy. Poor self-efficacy leads to social anxiety and ultimately deficiencies in diabetes. There is also a correlation among health literacy, self-efficacy, and social anxiety. Thus, the present study aimed to evaluate the impact of a literacy promotion training program based on social learning theory on the self-efficacy and social anxiety of adolescents with T1DM...
March 15, 2024: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/38461278/case-report-glycaemic-management-and-pregnancy-outcomes-in-a-woman-with-an-insulin-receptor-mutation-p-met1180lys
#6
JOURNAL ARTICLE
Mairéad T Crowley, Eirena Goulden, Begona Sanchez-Lechuga, Aileen Fleming, Maria Kennelly, Ciara McDonnell, Maria M Byrne
BACKGROUND: Heterozygous insulin receptor mutations (INSR) are associated with insulin resistance, hyperglycaemia and hyperinsulinaemic hypoglycaemia in addition to hyperandrogenism and oligomenorrhoea in women. Numerous autosomal dominant heterozygous mutations involving the INSR β-subunit tyrosine kinase domain resulting in type A insulin resistance have been previously described. We describe the phenotype, obstetric management and neonatal outcomes in a woman with type A insulin resistance caused by a mutation in the β-subunit of the INSR...
March 10, 2024: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/38402223/social-determinants-of-health-and-diabetes-using-a-nationally-representative-sample-to-determine-which-social-determinant-of-health-model-best-predicts-diabetes-risk
#7
JOURNAL ARTICLE
Zach W Cooper, Orion Mowbray, Leslie Johnson
OBJECTIVES: Social determinants of health (SDOH) research demonstrates poverty, access to healthcare, discrimination, and environmental factors influence health outcomes. Several models are commonly used to assess SDOH, yet there is limited understanding of how these models differ regarding their ability to predict the influence of social determinants on diabetes risk. This study compares the utility of four SDOH models for predicting diabetes disparities. STUDY DESIGN: We utilized The National Longitudinal Study of Adolescent to Adulthood (Add Health) to compare SDOH models and their ability to predict risk of diabetes and obesity...
February 25, 2024: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/38336931/efficacy-and-safety-of-fixed-dose-combination-of-sitagliptin-metformin-and-pioglitazone-in-type-2-diabetes-impact-study-a-randomized-controlled-trial
#8
JOURNAL ARTICLE
Mondal Aashish, Naskar Arindam, Sheelu Shafiq Siddiqi, Deepak Bhosle, V J Mallikarjuna, Dange Amol, Sorate Sanket, Gavali Omkar, Patel Parth, Hasnani Dhruvi, Prasad Durga, Dalwadi Pradeep, Kumar Suresh, Pathak Vaishali, Chaudhari Mayura, Basu Indraneel, Shembalkar Jayashri, Fariooqui Arif, S K Raghavendra, Varade Deepak, Thakkar Ravindra, Bhanushali Shaishav, Gaikwad Vijay, Kamran Khan, V V Mahajani, A D Sharma, Mayur Mayabhate, R R Pawar, A S Aiwale, Shahavi Vinayaka
BACKGROUND: Due to the progressive decline in β-cell function, it is often necessary to utilize multiple agents with complementary mechanisms of action to address various facets and achieve glycemic control. Thus, this study aimed to evaluate the efficacy and safety of a fixed-dose combination (FDC) of metformin/sitagliptin/pioglitazone (MSP) therapy vs. metformin/sitagliptin (MS) in type 2 diabetes mellitus (T2DM). METHODS: In this phase 3, multicenter, double-blind study, patients with T2DM who exhibited inadequate glycemic control with HbA1c of 8...
February 10, 2024: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/38317215/graves-disease-is-associated-with-increased-risk-of-clinical-alzheimer-s-disease-evidence-from-the-medicare-system
#9
JOURNAL ARTICLE
Arseniy Pavlovich Yashkin, Stanislav Kolpakov, Svetlana Ukraintseva, Anatoliy Yashin, Igor Akushevich
BACKGROUND: Identification of modifiable risk factors for Alzheimer's Disease (AD) onset is an important aspect of controlling the burden imposed by this disease on an increasing number of older U.S. adults. Graves disease (GD), the most common cause of hyperthyroidism in the U.S., has been hypothesized to be associated with increased AD risk, but there is no consensus. In this study, we explore the link between GD and risk of clinical AD. METHODS: Cox and Fine-Grey models were applied to a retrospective propensity-score-matched cohort of 19,798 individuals with GD drawn from a nationally representative 5% sample of U...
February 5, 2024: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/38281042/treatment-of-glucocorticoid-induced-hyperglycemia-in-hospitalized-patients-a-systematic-review-and-meta-analysis
#10
JOURNAL ARTICLE
Tristan Struja, Neele Nitritz, Islay Alexander, Kevin Kupferschmid, Jason F Hafner, Carlos C Spagnuolo, Philipp Schuetz, Beat Mueller, Claudine A Blum
PURPOSE: Glucocorticoid (GC)-induced hyperglycemia is a frequent issue, however there are no specific guidelines for this diabetes subtype. Although treat-to-target insulin is recommended in general to correct hyperglycemia, it remains unclear which treatment strategy has a positive effect on outcomes. We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) to assess whether treating GC-induced hyperglycemia improves clinical outcomes. METHODS: MEDLINE and EMBASE were systematically searched for RCTs on adults reporting treatment and outcomes of GC-induced hyperglycemia since the beginning of the data bases until October 21, 2023...
January 27, 2024: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/38267992/predictors-of-lack-of-glycemic-control-in-persons-with-type-2-diabetes
#11
JOURNAL ARTICLE
Judy Z Louie, Dov Shiffman, Charles M Rowland, Norma S Kenyon, Ernesto Bernal-Mizrachi, Michael J McPhaul, Rajesh Garg
BACKGROUND: Professional guidelines recommend an HbA1c < 7% for most people with diabetes and < 8.5% for those with relaxed glycemic goals. However, many people with type 2 diabetes mellitus (T2DM) are unable to achieve the desired HbA1c goal. This study evaluated factors associated with lack of improvement in HbA1c over 3 years. METHODS: All patients with T2DM treated within a major academic healthcare system during 2015-2020, who had at least one HbA1c value > 8...
January 25, 2024: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/38195551/the-association-between-bilirubin-levels-and-the-incidence-of-metabolic-syndrome-and-diabetes-mellitus-a-systematic-review-and-meta-analysis-of-cohort-studies
#12
REVIEW
Maziar Nikouei, Mojtaba Cheraghi, Faezeh Ghaempanah, Parisa Kohneposhi, Nadia Saniee, Sirous Hemmatpour, Yousef Moradi
OBJECTIVES: The objective of this meta-analysis was to investigate the association between plasma bilirubin levels and the incidence of metabolic syndrome and diabetes mellitus across all populations. METHODS: Several databases were searched, including PubMed (Medline), Scopus, Web of Science, and Embase (Elsevier), to identify relevant cohort studies. All cohort studies that reported the risk ratio along with a 95% confidence interval were included. The association between bilirubin levels and metabolic syndrome or diabetes was reported as a pooled RR with a 95% CI in the forest plot...
January 10, 2024: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/38098129/an-audit-of-the-use-of-ct-pituitary-scans-to-exclude-a-pituitary-macroadenoma
#13
JOURNAL ARTICLE
Lisa Douglas, James Caldwell, Mark Bolland
BACKGROUND: Pituitary imaging is often required to exclude an adenoma suspected clinically or biochemically. Although magnetic resonance (MR) is the gold standard, computerised tomography (CT) is faster, cheaper and induces less claustrophobia. Our audit at Auckland City Hospital, New Zealand, investigated whether the use of CT of the pituitary as the first line imaging to assess for a pituitary macroadenoma reduces the need for MR. METHODS: We investigated the usefulness of CT pituitary imaging in the exclusion of pituitary macroadenoma between 2012 and 2020...
December 15, 2023: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/38071328/the-effect-of-parental-diabetes-prevention-program-participation-on-weight-loss-in-dependent-children-a-prospective-cohort-study
#14
JOURNAL ARTICLE
Namratha Atluri, Joshua Thariath, Laura N McEwen, Wen Ye, MinKyoung Song, William H Herman
INTRODUCTION: Obesity has reached epidemic proportions in children and adolescents in the United States. Children's behaviors are strongly influenced by parental behaviors, and weight loss in parents is positively associated with weight changes in their overweight/obese children. Research is limited on how parents' National Diabetes Prevention Program (DPP) participation affects the health outcomes of their dependent children. Analyzing the impact of parental DPP participation on weight loss in their dependent children may provide valuable insight into an important secondary benefit of DPP participation...
December 10, 2023: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/37974292/assessment-homa-as-a-predictor-for-new-onset-diabetes-mellitus-and-diabetic-complications-in-non-diabetic-adults-a-koges-prospective-cohort-study
#15
JOURNAL ARTICLE
Jibeom Lee, Moon-Hyun Kim, Ji-Yong Jang, Chang-Myung Oh
BACKGROUND: Homeostasis model assessment for insulin resistance (HOMA-IR) is a biomarker for type 2 diabetes mellitus (T2DM). However, the role of HOMA-IR in the non-diabetic is unclear. This study aimed to determine whether IR measured HOMA-IR value is associated with new onset diabetes as well as vascular disease and can be used as an early predictor for diabetes and vascular diseases in non-diabetic participants. METHODS: From a prospective community-based cohort of 10,030 individuals, 4314 individuals younger than 65 years and without diabetes were enrolled and divided into three groups by baseline HOMA-IR tertiles: low (n = 1454), moderate (n = 1414), and high (n = 1446)...
November 16, 2023: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/37964325/prevalence-and-risk-factors-of-diabetes-foot-ulcers-in-kano-northwestern-nigeria
#16
JOURNAL ARTICLE
Raliyatu Aliyu, Ibrahim D Gezawa, Andrew E Uloko, Mansur A Ramalan
BACKGROUND: Foot complications account for more hospital admissions than any other diabetes mellitus (DM) complications with adverse outcomes being foot ulcers and amputation. OBJECTIVE: To determine the prevalence and risk factors of diabetic foot ulcers in Kano, Northwestern Nigeria. METHODS: A descriptive cross-sectional study was conducted in the diabetes outpatient clinics and medical and surgical wards of two hospitals in Kano, Nigeria...
November 14, 2023: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/37908013/pituitary-macroadenomas-in-childhood-and-adolescence-a-clinical-analysis-of-7-patients
#17
JOURNAL ARTICLE
Cristina Aguilar-Riera, María Clemente, Núria González-Llorens, Eduard Mogas, Ariadna Campos-Martorell, Anna Fàbregas, Betina Biagetti, Elida Vázquez, Diego Yeste
BACKGROUND: Pituitary adenomas (PPAs) are uncommon in childhood and adolescence, accounting for 2-6% of all intracranial neoplasms. Delayed puberty, growth retardation, galactorrhea and weight gain are common features at presentation in pediatric patients. Functional tumors constitute a vast majority (90%) of PPAs, with the most frequent being prolactinomas. CASE PRESENTATION: A retrospective review of the clinical features and outcomes of 7 pediatric patients with pituitary macroadenomas was conducted...
October 31, 2023: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/37865786/intermittent-fasting-consider-the-risks-of-disordered-eating-for-your-patient
#18
LETTER
Jack Blumberg, Samantha L Hahn, Jesse Bakke
This is a commentary on "Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians" by Albosta et al. While this article adequately summarized the biochemical clinical advantages and limitations, we feel it failed to mention a few drawbacks, primarily the risk for disordered eating and eating disorders. Here we delve into the emerging data on intermittent fasting or time-restricted feeding in patient populations and urge clinicians to consider these risks prior to encouragement of intermittent fasting...
October 21, 2023: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/37046323/multidisciplinary-intensive-lifestyle-intervention-improves-markers-of%C3%A2-nonalcoholic-fatty-liver-disease-nafld-in-patients-with-type-1-diabetes-and-obesity-a-retrospective-matched-cohort-study
#19
JOURNAL ARTICLE
Shaheen Tomah, Tareq Salah, Marwa Al-Badri, Shilton Dhaver, Hannah Gardner, Mhd Wael Tasabehji, Osama Hamdy
BACKGROUND: The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing among patients with type 1 diabetes (T1D) paralleling the increasing prevalence of obesity among this population. However, little is known about the impact of intensive lifestyle intervention (ILI) on NAFLD in patients with T1D. METHODS: Using Hepatic Steatosis Index (HSI), a noninvasive surrogate predictor of NAFLD, we retrospectively evaluated 88 adult patients with T1D and obesity after one year of participating in a 12-week ILI program in real-world clinical practice...
April 12, 2023: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/36922876/significant-risk-of-repeat-adverse-outcomes-in-recurrent-gestational-diabetes-pregnancy-a-retrospective-cohort-study
#20
JOURNAL ARTICLE
Sue Lynn Lau, Alex Chung, Joanna Kao, Susan Hendon, Wendy Hawke, Sue Mei Lau
BACKGROUND: The risk of adverse outcomes in recurrent GDM pregnancy has not been well documented, particularly in women who have already had an adverse outcome. The aim of this study was to compare the risk of recurrent adverse delivery outcome (ADO) or adverse neonatal outcome (ANO) between consecutive gestational diabetes (GDM) pregnancies. METHODS: In this retrospective study of 424 pairs of consecutive ("index" and "subsequent") GDM pregnancies, we compared the risk of ADO (instrumental delivery, emergency Caesarean section) and ANO (large for gestational age (LGA and small for gestational age (SGA)) in women with and without a history of adverse outcome in their index pregnancy...
March 15, 2023: Clinical Diabetes and Endocrinology
journal
journal
52472
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.